Compass Therapeutics (CMPX) PT Lowered to $7 at Canaccord
Canaccord analyst John Newman lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)